A Clinical Trial to Study the Effects of Nanoparticle Based Paclitaxel Drug, Which Does Not Contain the Solvent Cremophor, in Advanced Breast Cancer

Clinical trial NCT00915369 · UNKNOWN

Trial details

NCT number: NCT00915369
Sponsor: Fresenius Kabi Oncology Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Breast Cancer

Start date: 2009-03-01
Primary completion: 2010-04-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.